IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile Infection.
(2012) In Clinical and Vaccine Immunology 19(9). p.1552-1554- Abstract
- IgG antibodies against Clostridium difficile toxins A and B were followed in controls and patients with an initial C. difficile infection (CDI). Of the 50 CDI patients, 38 were cured and 12 developed recurrence. Compared to controls, patients had significantly lower anti-toxin A and B IgGs at inclusion, but the subsequent levels rose slightly regardless of clinical outcome. The results imply that the general serum reactivity against toxins A and B in the population reduces the risk of CDI, which suggests implications for vaccine strategies.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2967213
- author
- Wullt, Marlene LU ; Norén, T ; Ljungh, A and Akerlund, T
- organization
- publishing date
- 2012
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Clinical and Vaccine Immunology
- volume
- 19
- issue
- 9
- pages
- 1552 - 1554
- publisher
- American Society for Microbiology
- external identifiers
-
- wos:000308503400029
- pmid:22787196
- scopus:84865966570
- pmid:22787196
- ISSN
- 1556-6811
- DOI
- 10.1128/CVI.00210-12
- language
- English
- LU publication?
- yes
- id
- b14d060e-2362-4ded-aeaa-716a398247ad (old id 2967213)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/22787196?dopt=Abstract
- date added to LUP
- 2016-04-04 07:42:32
- date last changed
- 2022-04-23 08:34:31
@article{b14d060e-2362-4ded-aeaa-716a398247ad, abstract = {{IgG antibodies against Clostridium difficile toxins A and B were followed in controls and patients with an initial C. difficile infection (CDI). Of the 50 CDI patients, 38 were cured and 12 developed recurrence. Compared to controls, patients had significantly lower anti-toxin A and B IgGs at inclusion, but the subsequent levels rose slightly regardless of clinical outcome. The results imply that the general serum reactivity against toxins A and B in the population reduces the risk of CDI, which suggests implications for vaccine strategies.}}, author = {{Wullt, Marlene and Norén, T and Ljungh, A and Akerlund, T}}, issn = {{1556-6811}}, language = {{eng}}, number = {{9}}, pages = {{1552--1554}}, publisher = {{American Society for Microbiology}}, series = {{Clinical and Vaccine Immunology}}, title = {{IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile Infection.}}, url = {{http://dx.doi.org/10.1128/CVI.00210-12}}, doi = {{10.1128/CVI.00210-12}}, volume = {{19}}, year = {{2012}}, }